Mgi Pharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MGI PHARMA INC
MGI PHARMA INC has one approved drug.
Summary for Mgi Pharma Inc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Mgi Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mgi Pharma Inc | DIDRONEL | etidronate disodium | INJECTABLE;INJECTION | 019545-001 | Apr 20, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mgi Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mgi Pharma Inc | DIDRONEL | etidronate disodium | INJECTABLE;INJECTION | 019545-001 | Apr 20, 1987 | 3,683,080 | ⤷ Start Trial |
| Mgi Pharma Inc | DIDRONEL | etidronate disodium | INJECTABLE;INJECTION | 019545-001 | Apr 20, 1987 | 4,216,211 | ⤷ Start Trial |
| Mgi Pharma Inc | DIDRONEL | etidronate disodium | INJECTABLE;INJECTION | 019545-001 | Apr 20, 1987 | 4,254,114 | ⤷ Start Trial |
| Mgi Pharma Inc | DIDRONEL | etidronate disodium | INJECTABLE;INJECTION | 019545-001 | Apr 20, 1987 | 4,137,309 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
